Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

32 results
  1. ... Disorders see Eating Disorders Appetite Regulation WI 102 Appetite Suppressants see Appetite Depressants Appetitive Behavior BF 685 Animal ... Agents) WA 712 ft$* (Appetite) WI 102 ftgfcSciSIH (Appetite Suppressants) liftScWSiJU^aj: ft&Pf* (Appetite Disorders) (£f5ftP£*$££ Mkmffi ( ...
  2. NLM Digital Collections - Controversies in obesity management : a technology assessment : final report 
    Publication: [Boston, MA] : Institute for Clinical and Economic Review, August 10, 2015
    ... Lorcaserin is a selective serotonin 2C agonist with appetite-suppressant effects. Because of its potential to affect cognition ... Qsymia is a fixed-dose combination of the appetite suppressant phentermine and the anti-seizure medication topiramate.17 ...
  3. NLM Digital Collections - National Library of Medicine classification : a scheme for the shelf arrangement of library ... 
    Publication: Bethesda, Md. : U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Library of Medicine ; Washington, DC : For sale by the Supt. of Docs., U.S. G.P.O., 1999
    ... Used for a specific disorder, with the disorder Appetite Suppressants see Appetite Depressants Appetitive Behavior BF 685 Animal aspects QL 758- ... Food Inspection WA 695 Food Intake Regulation see Appetite Regulation Food, ... for see Gout Suppressants QV 98 Gout Suppressants QV 98 Governing Board ...
  4. ... Sustained Release Capsules NEW BAMADEX SEQUELS contain the appetite-suppressant, d-amphetamine, e ffectively balanced with the tranquilizer, meprobamate, for sustained, effective appetite control without overstimulation of the central nervous system. ...
  5. NLM Digital Collections - The Surgeon General's Report on Nutrition and Health (pages 276-300) 
    Publication: United States. Public Health Service. Office of the Surgeon General, 1988
    ... often regained than with other methods, suggesting that appetite-suppressant drugs lower the set point level at which body weight is regulated and only secondarily suppress appetite (Stunkard 1982). Regardless, weight loss would be expected ...
  6. NLM Digital Collections - The Surgeon General's Report on Nutrition and Health 
    Publication: United States. Public Health Service. Office of the Surgeon General, 1988
    ... often regained than with other methods, suggesting that appetite-suppressant drugs lower the set point level at which body weight is regulated and only secondarily suppress appetite (Stunkard 1982). Regardless, weight loss would be expected ...
  7. NLM Digital Collections - F as in fat : how obesity policies are failing in America 
    Publication: Washington, DC : Trust for America's Health, October 2004
    ... In 1997, the FDA approved a long-term appetite suppressant, Meridia (sibutramine), and it with- drew dexfenfluramine and fenfluramine because these drugs were linked to heart valve defects. In April of ... with appetite suppressors are the risks of tolerance and dependency. ...
  8. NLM Digital Collections - The Health Consequences of Smoking: Nicotine Addiction: A Report of the Surgeon General 
    Publication: Center for Health Promotion and Education (U.S.). Office on Smoking and Health, 1988
    ... D. Relationship between anorectic and reinforcing properties of appetite suppressant drugs: Implications for assessment of abuse liability. Biological ...
  9. NLM Digital Collections - The Health Consequences of Smoking: Nicotine Addiction: A Report of the Surgeon General ... 
    Publication: Center for Health Promotion and Education (U.S.). Office on Smoking and Health, 1988
    ... D. Relationship between anorectic and reinforcing properties of appetite suppressant drugs: Implications for assessment of abuse liability. Biological ...
  10. NLM Digital Collections - Pharmacological management of glycaemic control in people with type 2 diabetes : a national ... 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), November 2017
    ... with other health professionals. In keeping with the appetite-suppressant effect of these agents (albiglutide, dulaglutide, exenatide, liraglutide ...
first · previous · 1 · 2 · 3 · 4 · next · last